Lymphocyte activation gene 3 and coronary artery disease
Diana Golden, Antonina Kolmakova, Sunitha Sura, Anthony T. Vella, Ani Manichaikul, Xin-Qun Wang, Suzette J. Bielinski, Kent D. Taylor, Yii-Der Ida Chen, Stephen S. Rich, Annabelle Rodriguez
Diana Golden, Antonina Kolmakova, Sunitha Sura, Anthony T. Vella, Ani Manichaikul, Xin-Qun Wang, Suzette J. Bielinski, Kent D. Taylor, Yii-Der Ida Chen, Stephen S. Rich, Annabelle Rodriguez
View: Text | PDF
Clinical Research and Public Health Cardiology Inflammation

Lymphocyte activation gene 3 and coronary artery disease

Abstract

BACKGROUND: The lipoprotein scavenger receptor BI (SCARB1) rs10846744 noncoding variant is significantly associated with atherosclerotic disease independently of traditional cardiovascular risk factors. We identified a potentially novel connection between rs10846744, the immune checkpoint inhibitor lymphocyte activation gene 3 (LAG3), and atherosclerosis.

METHODS: In vitro approaches included flow cytometry, lipid raft isolation, phosphosignaling, cytokine measurements, and overexpressing and silencing LAG3 protein. Fasting plasma LAG3 protein was measured in hyperalphalipoproteinemic (HALP) and Multi-Ethnic Study of Atherosclerosis (MESA) participants.

RESULTS: In comparison with rs10846744 reference (GG homozygous) cells, LAG3 protein levels by flow cytometry (P < 0.001), in lipid rafts stimulated and unstimulated (P = 0.03), and phosphosignaling downstream of B cell receptor engagement of CD79A (P = 0.04), CD19 (P = 0.04), and LYN (P = 0.001) were lower in rs10846744 risk (CC homozygous) cells. Overexpressing LAG3 protein in risk cells and silencing LAG3 in reference cells confirmed its importance in phosphosignaling. Secretion of TNF-α was higher (P = 0.04) and IL-10 was lower (P = 0.04) in risk cells. Plasma LAG3 levels were lower in HALP carriers of the CC allele (P < 0.0001) and by race (P = 0.004). In MESA, race (P = 0.0005), age (P = 0.003), lipid medications (P = 0.03), smoking history (P < 0.0001), and rs10846744 genotype (P = 0.002) were independent predictors of plasma LAG3. In multivariable regression models, plasma LAG3 was significantly associated with HDL-cholesterol (HDL-C) (P = 0.007), plasma IL-10 (P < 0.0001), and provided additional predictive value above the Framingham risk score (P = 0.04). In MESA, when stratified by high HDL-C, plasma LAG3 was associated with coronary heart disease (CHD) (odds ratio 1.45, P = 0.004).

CONCLUSION: Plasma LAG3 is a potentially novel independent predictor of HDL-C levels and CHD risk.

FUNDING: This work was supported by an NIH RO1 grant (HL075646), the endowed Linda and David Roth Chair for Cardiovascular Research, and the Harold S. Geneen Charitable Trust Coronary Heart Disease Research award to Annabelle Rodriguez. MESA is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169, UL1-TR-001079, UL1-TR-000040, and DK063491. Cardiometabochip genotyping data for the MESA samples was supported in part by grants and contracts R01HL98077, N02-HL-64278, HL071205, UL1TR000124, DK063491, RD831697, and P50 ES015915.

Authors

Diana Golden, Antonina Kolmakova, Sunitha Sura, Anthony T. Vella, Ani Manichaikul, Xin-Qun Wang, Suzette J. Bielinski, Kent D. Taylor, Yii-Der Ida Chen, Stephen S. Rich, Annabelle Rodriguez

×

Figure 2

Differential expression of LAG3 protein and cytokine effects in SCARB1 rs10846744 reference (GG) and risk (CC) cells.

Options: View larger image (or click on image) Download as PowerPoint
Differential expression of LAG3 protein and cytokine effects in SCARB1 r...
EBV-transformed B lymphocytes homozygous for the reference (GG) or risk (CC) allele were incubated under basal or stimulated cocktail (500 ng/ml PMA, 250 ng/ml ionomycin, and 100 U/ml IL-4) conditions for 0–4 hours and stained with isotype control or anti–human LAG3-PE monoclonal antibody for measurement of percentage cell surface LAG3 protein, and then fixed for flow cytometry. (A) Reference cells (003 cell line) under basal and stimulated conditions were stained with isotype control or LAG3 antibodies; the data are representative of 1 of 3 independent experiments. (B) Risk cells (008 cell line) under basal and stimulated conditions were stained with isotype control or anti–human LAG3-PE monoclonal antibody; the data are representative of 1 of 3 independent experiments. (C) Graphic analysis of percentage cell surface protein expression of LAG3+ cells as measured by flow cytometry. Top left panel represents pooled data (mean ± SEM) of 3 independent experiments from the reference (GG-003) cells, each experiment performed with triplicate samples (n = 9, P < 0.001 compared with baseline). Top right panel represents pooled data (mean ± SEM) from 3 independent reference cell lines (n = 18, P < 0.001 compared with baseline). Bottom left presents pooled data (mean ± SEM) of 3 independent experiments from the risk (CC-008) cells, each experiment performed with triplicate samples (n = 9, P = 0.06). Bottom right panel represents pooled data (mean ± SEM) from all the risk cell lines (n = 15, P = 0.04). (D) Changes in LAG3 protein levels in the media over time following cocktail (PMA/ionomycin+IL-4) stimulation in reference-expressing and risk-expressing cells. Top panel represents pooled data (mean ± SEM) of 3 independent experiments from the reference (GG-003) cell line, each experiment performed with duplicate samples (n = 6, *P = 0.03 compared with baseline), and from pooled data (mean ± SEM) of 3 independent experiments from the risk (CC-008) cell line, each experiment performed with duplicate samples (n = 6, P ≥ 0.05, not significant). Bottom panel represents pooled data (mean ± SEM) from all the reference cell lines (n = 12, P ≥ 0.05, not significant) and pooled data (mean ± SEM) from all the risk cell lines (n = 10, P ≥ 0.05, not significant). Quadratic polynomial statistical analyses were performed to test significance.